Simpson Jennifer K. 4
4 · Panbela Therapeutics, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Simpson Jennifer K.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2024-10-01+72,800→ 72,800 totalExercise: $0.39Exp: 2034-10-01→ Common Stock (72,800 underlying)
Footnotes (1)
- [F1]The option fully vests on October 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.